Krystal Biotech Inc - ESG Rating & Company Profile powered by AI
If you are employed by Krystal Biotech Inc and you wish to use your Sustainability aseessment, please contact us. Jump to the bottom of the page for potential risks for Krystal Biotech Inc based on sector, geography and size. Full Sustainability assessment of Krystal Biotech Inc are accessed by registering for free.
Krystal Biotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 6.0, social score of 1.6 and governance score of 8.0.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 658 | Transchem Ltd | 5.3 | High |
| 658 | Zenith Healthcare Ltd | 5.3 | High |
| 687 | Krystal Biotech Inc | 5.2 | High |
| 687 | Cardiol Therapeutics Inc | 5.2 | High |
| 687 | Cell Source Inc | 5.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Krystal Biotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Krystal Biotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Krystal Biotech Inc report the average age of the workforce?
Sign up for free to unlockDoes Krystal Biotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Krystal Biotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Krystal Biotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Krystal Biotech Inc offer flexible work?
Sign up for free to unlockDoes Krystal Biotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Krystal Biotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Krystal Biotech Inc conduct supply chain audits?
Sign up for free to unlockDoes Krystal Biotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Krystal Biotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Krystal Biotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Krystal Biotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Krystal Biotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Krystal Biotech Inc disclose water use targets?
Sign up for free to unlockDoes Krystal Biotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Krystal Biotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes Krystal Biotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Krystal Biotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Krystal Biotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Krystal Biotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes Krystal Biotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Krystal Biotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Krystal Biotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Krystal Biotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Krystal Biotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Krystal Biotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Krystal Biotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Krystal Biotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Krystal Biotech Inc disclose its waste policy?
Sign up for free to unlockDoes Krystal Biotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes Krystal Biotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Krystal Biotech Inc disclose energy use targets?
Sign up for free to unlockDoes Krystal Biotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Krystal Biotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Krystal Biotech Inc
These potential risks are based on the size, segment and geographies of the company.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.